INTERNATIONAL PATENT: PRINCIPIA BIOPHARMA INC. FILES APPLICATION FOR "TOLEBRUTINIB FOR MULTIPLE SCLEROSIS"

GENEVA, March 11 -- PRINCIPIA BIOPHARMA INC. (100 Morris StreetMorristown, New Jersey 07960) filed a patent application (PCT/US2025/043964) for "TOLEBRUTINIB FOR MULTIPLE SCLEROSIS" on Aug 28, 2025. With publication no. WO/2026/050513, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DUKOVIC, Deborah (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), SYED, Sana (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), TURNER, Timothy J. (c/o Sanofi, Patent Department450 Wate...